CollPlant Biotechnologies Ltd.

CLGN | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.13

-$0.17 (-3.95%)

Sep 22, 2026, 2:32 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-3.95%

(1D)

Rating

Updated: Sep 5, 2026

29.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $5.36M

1D Range

4.02 4.50

52W Range

2.64 31.80

Valuation (TTM)

PE -0.42

PB 1.14

EV/EBITDA -0.33

Valuation (NTM)

Forward PE 140.00

Forward PEG 0.01

Price Target $12.50

Cash Flow

FCF Yield -208.1%

SBC Adj. FCF Yield -222.8%

SBC Impact -7.0%

Margins

Gross Margin -319.3%

Operating Margin -3329.1%

FCF Margin -2982.6%

Growth (CAGR)

Revenue 3Y | 5Y -16.4% | -54.5%

Dil EPS 3Y | 5Y -18.5% | 7.4%

FCF 3Y | 5Y -44.5% | 5.4%

Returns

ROA -143.0%

ROE -160.3%

ROIC -171.9%

Financial Health

Net Cash

$4.26M

Current Ratio 2.27

Interest Coverage -57.30

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

CollPlant Biotechnologies Ltd. is a regenerative and aesthetic medicine enterprise operating across the United States, Canada, and Europe. The company primarily engages in the three-dimensional (3D) b...

Sector Healthcare

Industry Biotechnology

Employees 39

IPO Date Jan 30, 2018

Website www.collplant.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Dec 2, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Hold

Price Target

$12.50

Upside

+202.66%

Buy (0)

Hold (1)

Sell (0)

Analyst Details ➞